dpp4 with glp 1 The mechanism of action of GLP-1 analogs (DPP-4 resistant). DPP-4 = Cardiovascular effects of DPP-4 inhibition:

Dissemination to participants and related patient and public communities: No plans are currently in place to disseminate the results to study participants

If youre not eligible for GLP-1 medications, there are a number of alternatives that you can try to achieve the same results

Bisaga, A., Danysz, W

Am J Obstet Gynecol (1995) 173(3 Pt 1):7607

Your provider will evaluate your unique health needs to determine if Mounjaro (Tirzepatide) is the right treatment for you

For instance, Lixisenatide was evaluated for safety, efficacy, and adverse events in a randomized, double-blind, placebo-controlled, parallel-group, 13-week study of 542 patients with Type 2 diabetes inadequately controlled on metformin (1000 mg/day) treated with subcutaneous lixisenatide doses of 5, 10, 20, or 30 g once daily or twice daily or placebo